These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 18937621)

  • 1. Vinorelbine in breast cancer.
    Bonneterre J; Penel N
    Expert Opin Pharmacother; 2008 Nov; 9(16):2901-10. PubMed ID: 18937621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vinorelbine. A review of its pharmacological properties and clinical use in cancer chemotherapy.
    Goa KL; Faulds D
    Drugs Aging; 1994 Sep; 5(3):200-34. PubMed ID: 7803948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Oral vinorelbine: pharmacology and treatment outcome in non-small cell bronchial carcinoma and breast carcinoma].
    Bartsch V
    Onkologie; 2006 Mar; 29 Suppl 1():1-28. PubMed ID: 16534241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects and toxicity of neoadjuvant chemotherapy with vinorelbine and cisplatin in treatment of operable breast cancer previously non-responsive to anthracyclines and taxanes-containing regimen: analysis of 19 cases].
    Xu L; Ye JM; Zhao JX; Duan XN; Liu YH
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):683-5. PubMed ID: 19595063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of vinorelbine monotherapy in advanced and metastatic breast cancer].
    Suehisa H; Aogi K; Hara F; Takabatake D; Takashima S; Ohsumi S; Takashima S; Komatsubara K
    Gan To Kagaku Ryoho; 2008 Oct; 35(10):1709-12. PubMed ID: 18931573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vinorelbine and the topoisomerase 1 inhibitors: current and potential roles in breast cancer chemotherapy.
    O'Reilly S; Kennedy MJ; Rowinsky EK; Donehower RC
    Breast Cancer Res Treat; 1995; 33(1):1-17. PubMed ID: 7749128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral vinorelbine (Navelbine) in the treatment of advanced breast cancer.
    Winer EP; Chu L; Spicer DV
    Semin Oncol; 1995 Apr; 22(2 Suppl 5):72-8; discussion 78-9. PubMed ID: 7740337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral vinorelbine in combination with trastuzumab as a first-line therapy of metastatic or locally advanced HER2-positive breast cancer.
    Farhat F; Kattan JG; Ghosn M
    Cancer Chemother Pharmacol; 2016 May; 77(5):1069-77. PubMed ID: 27059339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Final results of an international retrospective observational study in patients with advanced breast cancer treated with oral vinorelbine-based chemotherapy.
    Palomo AG; Glogowska I; Sommer H; Malamos N; Kilar E; Vega JM; Torrecillas L; Delozier T; Ettl J; Finek J
    Anticancer Res; 2012 Oct; 32(10):4539-45. PubMed ID: 23060583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capecitabine and vinorelbine in metastatic breast cancer.
    Chan A; Verrill M
    Eur J Cancer; 2009 Sep; 45(13):2253-65. PubMed ID: 19464166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of oral vinorelbine in combination with capecitabine as second line chemotherapy in metastatic breast cancer patients previously treated with anthracyclines and taxanes.
    Jones A; O'Brien M; Sommer H; Nowara E; Welt A; Pienkowski T; Rolski J; Pham ML; Perraud K; Trillet-Lenoir V
    Cancer Chemother Pharmacol; 2010 Mar; 65(4):755-63. PubMed ID: 19669644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer.
    Burstein HJ; Kuter I; Campos SM; Gelman RS; Tribou L; Parker LM; Manola J; Younger J; Matulonis U; Bunnell CA; Partridge AH; Richardson PG; Clarke K; Shulman LN; Winer EP
    J Clin Oncol; 2001 May; 19(10):2722-30. PubMed ID: 11352965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On and off metronomic oral vinorelbine in elderly women with advanced breast cancer.
    De Iuliis F; Salerno G; Taglieri L; Lanza R; Scarpa S
    Tumori; 2015; 101(1):30-5. PubMed ID: 25702645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective study of vinorelbine and capecitabine combination therapy in Chinese patients with metastatic breast cancer pretreated with anthracyclines and taxanes.
    Fan Y; Xu B; Yuan P; Wang J; Ma F; Li Q; Zhang P; Li Q; Cai R
    Chemotherapy; 2010; 56(4):340-7. PubMed ID: 20720418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vinorelbine: a novel vinca alkaloid.
    Toso C; Lindley C
    Am J Health Syst Pharm; 1995 Jun; 52(12):1287-304; quizz 1340-1. PubMed ID: 7656116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inability to escalate vinorelbine dose intensity using a daily x3 schedule with and without filgrastim in patients with metastatic breast cancer.
    Havlin KA; Ramirez MJ; Legler CM; Harris LN; Matulonis UA; Hohneker JA; Hayes DF; Winer EP
    Cancer Chemother Pharmacol; 1999; 43(1):68-72. PubMed ID: 9923543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-tumor activity of capecitabine and vinorelbine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: findings from the EORTC 10001 randomized phase II trial.
    Pajk B; Cufer T; Canney P; Ellis P; Cameron D; Blot E; Vermorken J; Coleman R; Marreaud S; Bogaerts J; Basaran G; Piccart M
    Breast; 2008 Apr; 17(2):180-5. PubMed ID: 17976988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capecitabine and vinorelbine in patients with metastatic breast cancer previously treated with anthracycline and taxane.
    Ahn JH; Kim SB; Kim TW; Ahn SH; Kim SM; Park JM; Lee JS; Kang YK; Kim WK
    J Korean Med Sci; 2004 Aug; 19(4):547-53. PubMed ID: 15308846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I trial of afatinib plus vinorelbine in Japanese patients with advanced solid tumors, including breast cancer.
    Mukai H; Masuda N; Ishiguro H; Mitsuma A; Shibata T; Yamamura J; Toi M; Watabe A; Sarashina A; Uttenreuther-Fischer M; Ando Y
    Cancer Chemother Pharmacol; 2015 Oct; 76(4):739-50. PubMed ID: 26254023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individualized chemotherapy based on organ selectivity: a retrospective study of vinorelbine and capecitabine for patients with metastatic breast cancer.
    Liu XH; Man YN; Cao R; Liu C; Wu XZ
    Curr Med Res Opin; 2014 Jun; 30(6):1017-24. PubMed ID: 24528110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.